WASHINGTON, DC, Nanochon, an orthopedic device biotech company, has raised $4 million in its series seed prime fundraising round.
Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from Cultivate (MD), Alumni Venture Group, and Mountain State Capital, among others.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
